Jordan Nadine N - OmicsDI

Browse
Submit Data
Databases
API
Help

2 Results

Show all Save search Copy query

Show results for

Metabolomics (2)

Repository

MetaboLights (2)

Technology Type

Mass spectrometry (2)

Instrument Platform

Q Exactive (2)

Publication Date

2024 (2)

CHEBI ID

CHEBI:46171 (2)
CHEBI:84814 (2)
CHEBI:73209 (2)
CHEBI:78266 (2)
CHEBI:78261 (2)
CHEBI:84829 (2)
CHEBI:45826 (2)
CHEBI:75062 (2)
CHEBI:84153 (2)
CHEBI:73218 (2)
CHEBI:33511 (2)
CHEBI:44673 (2)
CHEBI:84415 (2)
CHEBI:138368 (2)
CHEBI:133144 (2)
CHEBI:28116 (2)
CHEBI:75038 (2)
CHEBI:75034 (2)
CHEBI:84822 (2)
CHEBI:78268 (2)
CHEBI:74965 (2)
CHEBI:73000 (2)
CHEBI:133141 (2)
CHEBI:133139 (2)
CHEBI:133649 (2)
CHEBI:133647 (2)
CHEBI:36315 (2)
CHEBI:133672 (2)
CHEBI:74977 (2)
CHEBI:73009 (2)

Metabolite Name

Beta-citrylglutamate (2)
Propionylcarnitine (C3) (2)
Cysteinylglycine (2)
4-acetamidobenzoate (2)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)* (2)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)* (2)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)* (2)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)* (2)
1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4)* (2)
1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)* (2)
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)* (2)
1-stearoyl-2-linoleoyl-GPC (18:0/18:2)* (2)
Palmitoyl dihydrosphingomyelin (d18:0/16:0)* (2)
1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6) (2)
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) (2)
Behenoyl sphingomyelin (d18:1/22:0)* (2)
2-stearoyl-GPE (18:0)* (2)
1-(1-enyl-stearoyl)-GPE (P-18:0)* (2)
1-(1-enyl-palmitoyl)-GPE (P-16:0)* (2)
2-oxoarginine* (2)
1-palmitoyl-GPI (16:0) (2)
1-arachidonoyl-GPI (20:4)* (2)
1-myristoyl-2-palmitoyl-GPC (14:0/16:0) (2)
N-acetylglucosaminylasparagine (2)
Trans-4-hydroxyproline (2)
Thioproline (2)
Sphingosine (2)
Serotonin (2)
Ribonate (2)
Quinolinate (2)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

10

Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study

Post-acute sequelae of SARS-CoV-2 (PASC) is a significant public health concern. We describe Patient Reported Outcomes (PROs) on 590 participants prospectively assessed from hospital admission for COVID-19 through one year after discharge. Modeling identified 4 PRO clusters based on reported deficit...

2024-01-12 | MTBLS850 | MetaboLights

A metabolic dependency of EBV can be targeted to hinder B cell transformation

Following infection of B cells, Epstein Barr virus (EBV) engages host pathways that mediate cell proliferation and transformation, contributing to the propensity of the virus to drive immune dysregulation and lymphomagenesis. We found that the EBV protein EBNA2 initiates NAD de novo bios...

2024-04-29 | MTBLS2243 | MetaboLights

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

10

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data